Analysen von Emily Field

02.11.22 Merck Overweight Barclays Capital
01.11.22 AstraZeneca Overweight Barclays Capital
27.10.22 AstraZeneca Overweight Barclays Capital
19.10.22 Roche Overweight Barclays Capital
18.10.22 Roche Overweight Barclays Capital
14.10.22 Novo Nordisk Overweight Barclays Capital
10.10.22 Merck Overweight Barclays Capital
07.10.22 Merck Overweight Barclays Capital
03.10.22 Novo Nordisk Overweight Barclays Capital
29.09.22 Roche Overweight Barclays Capital
31.08.22 Bayer Overweight Barclays Capital
29.08.22 Bayer Overweight Barclays Capital
16.08.22 Merck Overweight Barclays Capital
15.08.22 Novo Nordisk Overweight Barclays Capital
15.08.22 Bayer Overweight Barclays Capital
04.08.22 Novo Nordisk Overweight Barclays Capital
04.08.22 AstraZeneca Overweight Barclays Capital
04.08.22 Merck Overweight Barclays Capital
18.07.22 Merck Overweight Barclays Capital
18.07.22 Novo Nordisk Overweight Barclays Capital
18.07.22 AstraZeneca Overweight Barclays Capital
18.07.22 Roche Overweight Barclays Capital
18.07.22 Bayer Overweight Barclays Capital
15.07.22 Bayer Overweight Barclays Capital
22.06.22 Bayer Overweight Barclays Capital
21.06.22 Bayer Overweight Barclays Capital
13.06.22 Novo Nordisk Overweight Barclays Capital
10.06.22 Bayer Overweight Barclays Capital
12.05.22 Merck Overweight Barclays Capital
12.05.22 Novo Nordisk Overweight Barclays Capital
11.05.22 Roche Overweight Barclays Capital
11.05.22 Bayer Overweight Barclays Capital
10.05.22 Bayer Overweight Barclays Capital
04.05.22 Merck Overweight Barclays Capital
26.04.22 Roche Overweight Barclays Capital
04.04.22 Bayer Overweight Barclays Capital
30.03.22 Roche Overweight Barclays Capital
04.03.22 Merck Overweight Barclays Capital
15.02.22 Novo Nordisk Overweight Barclays Capital
15.02.22 AstraZeneca Overweight Barclays Capital
07.02.22 Roche Overweight Barclays Capital
04.02.22 Roche Overweight Barclays Capital
31.01.22 Roche Overweight Barclays Capital
31.01.22 AstraZeneca Overweight Barclays Capital
31.01.22 Novo Nordisk Overweight Barclays Capital
21.12.21 Novo Nordisk Overweight Barclays Capital
22.11.21 Novo Nordisk Overweight Barclays Capital
10.11.21 AstraZeneca Overweight Barclays Capital
04.11.21 Novo Nordisk Overweight Barclays Capital
20.10.21 Roche Overweight Barclays Capital